Influence of assay methodologies and interferences on the interpretaiton of digoxin concentrationsFITZSIMMONS, W. E.Drug intelligence & clinical pharmacy. 1986, Vol 20, Num 7-8, pp 538-542, issn 0012-6578Article

Effect of Corticosteroid Withdrawal on Tacrolimus and Mycophenolate Mofetil Exposure in a Randomized Multicenter StudySHIHAB, F. S; LEE, S. T; FIRST, M. R et al.American journal of transplantation (Print). 2013, Vol 13, Num 2, pp 474-484, issn 1600-6135, 11 p.Article

One-year results with extended-release tacrolimus/ MMF, tacrolimus/MMF and cyclosporine/MMF in de novo kidney transplant recipientsSILVA, H. T; YANG, H. C; ABOULJOUD, M et al.American journal of transplantation (Print). 2007, Vol 7, Num 3, pp 595-608, issn 1600-6135, 14 p.Article

Conversion of stable liver transplant recipients from a twice-daily prograf-based regimen to a once-daily modified release tacrolimus-based regimenFLORMAN, S; ALLOWAY, R; WISEMANDLE, K et al.Transplantation proceedings. 2005, Vol 37, Num 2, pp 1211-1213, issn 0041-1345, 3 p.Conference Paper

Assessment of myocardial hypertrophy by echocardiography in adult patients receiving tacrolimus or cyclosporine therapy for prevention of acute GVHDESPINO, G; DENNEY, J; FURLONG, T et al.Bone marrow transplantation (Basingstoke). 2001, Vol 28, Num 12, pp 1097-1103, issn 0268-3369Article

Tacrolimus and minidose methotrexate for prevention of acute graft-versus-host disease after matched unrelated donor marrow transplantationPRZEPIORKA, D; IPPOLITI, C; DEISSEROTH, A. B et al.Blood. 1996, Vol 88, Num 11, pp 4383-4389, issn 0006-4971Article

Tacrolimus with mycophenolate mofetil (MMF) or sirolimus vs. cyclosporine with MMF in cardiac transplant patients : 1-year reportKOBASHIGAWA, J. A; MILLER, L. W; FITZSIMMONS, W et al.American journal of transplantation (Print). 2006, Vol 6, Num 6, pp 1377-1386, issn 1600-6135, 10 p.Article

Conversion of stable kidney transplant recipients from a twice daily prograf-based regimen to a once daily modified release tacrolimus-based regimenALLOWAY, R; STEINBERG, S; WISEMANDLE, K et al.Transplantation proceedings. 2005, Vol 37, Num 2, pp 867-870, issn 0041-1345, 4 p.Conference Paper

Tacrolimus pharmacokinetics in BMT patientsBOSWELL, G. W; BEKERSKY, I; FAY, J et al.Bone marrow transplantation (Basingstoke). 1998, Vol 21, Num 1, pp 23-28, issn 0268-3369Article

Pentamidine therapy in renal failure: case report and literature reviewFITZSIMMONS, W. E; LUSKIN, S. S.Drug intelligence & clinical pharmacy. 1988, Vol 22, Num 1, pp 25-28, issn 0012-6578Article

Relationship of FK506 whole blood concentrations and efficacy and toxicity after liver and kidney transplantationKERSHNER, R. P; FITZSIMMONS, W. E.Transplantation. 1996, Vol 62, Num 7, pp 920-926, issn 0041-1337Article

Cortical blindness : a rare complication of cyclosporine therapyGHALIE, R; FITZSIMMONS, W. E; BENNETT, D et al.Bone marrow transplantation (Basingstoke). 1990, Vol 6, Num 2, pp 147-149, issn 0268-3369, 3 p.Article

Pharmacokinetic evaluation of the terfenadine-theophylline interactionLUSKIN, S. S; FITZSIMMONS, W. E; MACLEOD, C. M et al.Journal of allergy and clinical immunology. 1989, Vol 83, Num 2, pp 406-411, issn 0091-6749, 1Article

Single dose comparison of the relative bioavailability of phenytoin suspension and extended capsulesFITZSIMMONS, W. E; GARNETT, W. R; COMSTOCK, T. J et al.Epilepsia (Copenhagen). 1986, Vol 27, Num 4, pp 464-468, issn 0013-9580Article

Glucocorticoids fail to enhance the effect of FK506 and methotrexate in prevention of graft-versus-host disease after DLA-nonidentical, unrelated marrow transplantationYU, C; SEIDEL, K; FITZSIMMONS, W. E et al.Bone marrow transplantation (Basingstoke). 1997, Vol 20, Num 2, pp 137-141, issn 0268-3369Article

Single-dose study of the effect of terfenadine on theophylline absorption and dispositionFITZSIMMONS, W. E; LUSKIN, S. S; MACLEOD, C. M et al.Annals of allergy. 1989, Vol 62, Num 3, pp 213-214, issn 0003-4738Article

4-Aminopyridine in multiple sclerosis : prolonged administrationSTEFOSKI, D; DAVIS, F. A; FITZSIMMONS, W. E et al.Neurology. 1991, Vol 41, Num 9, pp 1344-1348, issn 0028-3878Article

Effect of two administration schedules of an enteral nutrient formula on phenytoin bioavailabilityKRUEGER, K. A; GARNETT, W. R; COMSTOCK, T. J et al.Epilepsia (Copenhagen). 1987, Vol 28, Num 6, pp 706-712, issn 0013-9580Article

Pharmacokinetics and in vivo activity of liposome-encapsulated gentamicinSWENSON, C. E; STEWART, K. A; HAMMETT, J. L et al.Antimicrobial agents and chemotherapy. 1990, Vol 34, Num 2, pp 235-240, issn 0066-4804Article

Tacrolimus (FK506) and methotrexate regimens to prevent graft-versus-host disease after unrelated dog leukocyte antigen (DLA) nonidential marrow transplantationYU, C; DEEG, H. J; GRAHAM, T. C et al.Bone marrow transplantation (Basingstoke). 1996, Vol 17, Num 4, pp 649-653, issn 0268-3369Article

Effect of diphenoxylate with atropine sulfate on the bioavailability of quinidine sulfate in healthy subjectsPONZILLO, J. J; SCAVONE, J. M; PAONE, R. P et al.Clinical pharmacy. 1988, Vol 7, Num 2, pp 139-142, issn 0278-2677Article

FK 506 and rapamycin in combination are not antagonistic but produce extended small bowel graft survival in the mouseCHEN, H; QI, S; XU, D et al.Transplantation proceedings. 1998, Vol 30, Num 4, pp 1039-1041, issn 0041-1345Conference Paper

Combined effect of rapamycin and FK 506 in prolongation of small bowel graft survival in the mouseCHEN, H; QI, S; XU, D et al.Transplantation proceedings. 1998, Vol 30, Num 6, pp 2579-2581, issn 0041-1345Conference Paper

FK506 (Tacrolimus) monotherapy for prevention of graft-versus-host disease after histocompatible sibling allogeneic bone marrow transplantationFAY, J. W; WINGARD, J. R; MAHER, R. M et al.Blood. 1996, Vol 87, Num 8, pp 3514-3519, issn 0006-4971Article

Consensus document : therapeutic monitoring of tacrolimus (FK-506)JUSKO, W. J; THOMSON, A. W; MCBRIDE, J et al.Therapeutic drug monitoring. 1995, Vol 17, Num 6, pp 606-614, issn 0163-4356Conference Paper